Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ra Medical Systems Inc (RMED)

Ra Medical Systems Inc (RMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,141
  • Shares Outstanding, K 32,300
  • Annual Sales, $ 20 K
  • Annual Income, $ -25,070 K
  • 60-Month Beta 1.57
  • Price/Sales 405.95
  • Price/Cash Flow N/A
  • Price/Book 0.49
Trade RMED with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.63
  • Most Recent Earnings -0.27 on 05/16/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.77
  • Growth Rate Est. (year over year) +56,540.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2570 +17.24%
on 05/19/22
0.3900 -22.74%
on 04/29/22
-0.0447 (-12.92%)
since 04/20/22
3-Month
0.2570 +17.24%
on 05/19/22
0.7473 -59.68%
on 03/01/22
-0.0814 (-21.27%)
since 02/18/22
52-Week
0.2570 +17.24%
on 05/19/22
9.8200 -96.93%
on 06/07/21
-2.8487 (-90.43%)
since 05/20/21

Most Recent Stories

More News
Ra Medical Systems Reports First Quarter 2022 Financial Results

Ra Medical Systems, Inc . (NYSE American: RMED) (“Ra Medical” or “the Company”), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial...

RMED : 0.3013 (+6.47%)
Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

Ra Medical Systems, Inc . (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will...

RMED : 0.3013 (+6.47%)
Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area

Ra Medical Systems, Inc. (NYSE American: RMED) , a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office...

RMED : 0.3013 (+6.47%)
Ra Medical Systems Achieves Milestone of 100 Subjects Enrolled in its Pivotal Atherectomy Clinical Study

Ra Medical Systems, Inc. (NYSE American: RMED) , a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the achievement of a milestone with the enrollment...

RMED : 0.3013 (+6.47%)
Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

Ra Medical Systems, Inc . (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full...

RMED : 0.3013 (+6.47%)
Ra Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022

Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report 2021 fourth quarter and full year financial results after market close on Wednesday, March 23. Ra Medical management will hold...

RMED : 0.3013 (+6.47%)
Is Ra Medical Systems a Good Penny Stock to Own?

The shares of commercial-stage medical device maker Ra Medical Systems (RMED) have tumbled 92.7% in price over the past year due to investor concerns surrounding the company’s poor financial health....

RMED : 0.3013 (+6.47%)
ABT : 113.24 (+0.71%)
ELMD : 12.00 (-0.58%)
FONR : 15.75 (-2.54%)
Ra Medical Systems Files 510(k) Application for the DABRA Catheter with Braided Overjacket and Six-Month Shelf Life

Ra Medical Systems, Inc. (NYSE American: RMED) , a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the filing of a 510(k) application with the...

RMED : 0.3013 (+6.47%)
Ra Medical Systems Provides an Update on Enrollment in Its Pivotal Atherectomy Clinical Trial

Ra Medical Systems, Inc. (NYSE American: RMED) , a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollment has reached 95 subjects in its...

RMED : 0.3013 (+6.47%)
Ra Medical Systems Granted U.S. Patent for a Support Catheter for use Supporting a Liquid Core Ablation Catheter

Ra Medical Systems, Inc. (NYSE American: RMED) , a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces that on February 8, 2022, the United States...

RMED : 0.3013 (+6.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter...

See More

Key Turning Points

3rd Resistance Point 0.3575
2nd Resistance Point 0.3338
1st Resistance Point 0.3175
Last Price 0.3013
1st Support Level 0.2775
2nd Support Level 0.2538
3rd Support Level 0.2375

See More

52-Week High 9.8200
Fibonacci 61.8% 6.1669
Fibonacci 50% 5.0385
Fibonacci 38.2% 3.9101
Last Price 0.3013
52-Week Low 0.2570

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar